Ana Rodriguez-Mateos1, Catarina Rendeiro, Triana Bergillos-Meca, Setareh Tabatabaee, Trevor W George, Christian Heiss, Jeremy Pe Spencer. 1. Department of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom (AR-M, CR, TB-M, ST, TWG, and JPES); the Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Düsseldorf, Düsseldorf, Germany (AR-M and CH); and the Department of Applied Sciences, Faculty of Health and Life Sciences, University of Northumbria, Newcastle upon Tyne, United Kingdom (TWG).
Abstract
BACKGROUND: There are very limited data regarding the effects of blueberry flavonoid intake on vascular function in healthy humans. OBJECTIVES: We investigated the impact of blueberry flavonoid intake on endothelial function in healthy men and assessed potential mechanisms of action by the assessment of circulating metabolites and neutrophil NADPH oxidase activity. DESIGN: Two randomized, controlled, double-blind, crossover human-intervention trials were conducted with 21 healthy men. Initially, the impact of blueberry flavonoid intake on flow-mediated dilation (FMD) and polyphenol absorption and metabolism was assessed at baseline and 1, 2, 4, and 6 h after consumption of blueberry containing 766, 1278, and 1791 mg total blueberry polyphenols or a macronutrient- and micronutrient-matched control drink (0 mg total blueberry polyphenols). Second, an intake-dependence study was conducted (from baseline to 1 h) with 319, 637, 766, 1278, and 1791 mg total blueberry polyphenols and a control. RESULTS: We observed a biphasic time-dependent increase in FMD, with significant increases at 1-2 and 6 h after consumption of blueberry polyphenols. No significant intake-dependence was observed between 766 and 1791 mg. However, at 1 h after consumption, FMD increased dose dependently to ≤766 mg total blueberry polyphenol intake, after which FMD plateaued. Increases in FMD were closely linked to increases in circulating metabolites and by decreases in neutrophil NADPH oxidase activity at 1-2 and 6 h. CONCLUSIONS: Blueberry intake acutely improves vascular function in healthy men in a time- and intake-dependent manner. These benefits may be mechanistically linked to the actions of circulating phenolic metabolites on neutrophil NADPH oxidase activity. This trial was registered at clinicaltrials.gov as NCT01292954 and NCT01829542.
RCT Entities:
BACKGROUND: There are very limited data regarding the effects of blueberry flavonoid intake on vascular function in healthy humans. OBJECTIVES: We investigated the impact of blueberry flavonoid intake on endothelial function in healthy men and assessed potential mechanisms of action by the assessment of circulating metabolites and neutrophil NADPH oxidase activity. DESIGN: Two randomized, controlled, double-blind, crossover human-intervention trials were conducted with 21 healthy men. Initially, the impact of blueberry flavonoid intake on flow-mediated dilation (FMD) and polyphenol absorption and metabolism was assessed at baseline and 1, 2, 4, and 6 h after consumption of blueberry containing 766, 1278, and 1791 mg total blueberry polyphenols or a macronutrient- and micronutrient-matched control drink (0 mg total blueberry polyphenols). Second, an intake-dependence study was conducted (from baseline to 1 h) with 319, 637, 766, 1278, and 1791 mg total blueberry polyphenols and a control. RESULTS: We observed a biphasic time-dependent increase in FMD, with significant increases at 1-2 and 6 h after consumption of blueberry polyphenols. No significant intake-dependence was observed between 766 and 1791 mg. However, at 1 h after consumption, FMD increased dose dependently to ≤766 mg total blueberry polyphenol intake, after which FMD plateaued. Increases in FMD were closely linked to increases in circulating metabolites and by decreases in neutrophil NADPH oxidase activity at 1-2 and 6 h. CONCLUSIONS: Blueberry intake acutely improves vascular function in healthy men in a time- and intake-dependent manner. These benefits may be mechanistically linked to the actions of circulating phenolic metabolites on neutrophil NADPH oxidase activity. This trial was registered at clinicaltrials.gov as NCT01292954 and NCT01829542.
Authors: Matthew David Cook; Stephen David Myers; Mandy Lucinda Gault; Victoria Charlotte Edwards; Mark Elisabeth Theodorus Willems Journal: Eur J Appl Physiol Date: 2016-12-24 Impact factor: 3.078
Authors: Matthew David Cook; Stephen David Myers; Mandy Lucinda Gault; Victoria Charlotte Edwards; Mark Elisabeth Theodorus Willems Journal: Eur J Appl Physiol Date: 2017-04-08 Impact factor: 3.078
Authors: Sarah A Johnson; Negin Navaei; Shirin Pourafshar; Salvador J Jaime; Neda S Akhavan; Stacey Alvarez-Alvarado; Gabriela V Proaño; Nicole S Litwin; Elizabeth A Clark; Elizabeth M Foley; Kelli S George; Marcus L Elam; Mark E Payton; Bahram H Arjmandi; Arturo Figueroa Journal: J Med Food Date: 2020-05-19 Impact factor: 2.786
Authors: Zainie Aboo Bakkar; Jonathan Fulford; Phillip E Gates; Sarah R Jackman; Andrew M Jones; Bert Bond; Joanna L Bowtell Journal: J Appl Physiol (1985) Date: 2018-11-29
Authors: Matthew B Rivara; Rajnish Mehrotra; Lori Linke; John Ruzinski; T Alp Ikizler; Jonathan Himmelfarb Journal: J Ren Nutr Date: 2014-09-11 Impact factor: 3.655